{"id":28803,"date":"2025-07-27T19:59:06","date_gmt":"2025-07-27T19:59:06","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/breakthrough-in-light-therapy-koushicare-utilizes-dwvlllt-technology-to-treat-dry-eyes\/"},"modified":"2025-07-27T19:59:06","modified_gmt":"2025-07-27T19:59:06","slug":"breakthrough-in-light-therapy-koushicare-utilizes-dwvlllt-technology-to-treat-dry-eyes","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=28803","title":{"rendered":"Breakthrough in Light Therapy: KouShiCare utilizes DWV\u2122LLLT Technology to Treat Dry Eyes"},"content":{"rendered":"<p><span class=\"legendSpanClass\"><span class=\"xn-location\">HONG KONG<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 27, 2025<\/span><\/span> \/PRNewswire\/ &#8212; KouShiCare, a leading innovator in healthcare technology, is proud to announce a groundbreaking advancement in the treatment of dry eye disease. The company&#8217;s latest device harnesses the power of DWV\u2122 Low-Level Laser Therapy (LLLT) technology, marking a significant step forward in light-based ocular care.<\/p>\n<p>Approximately 344 million people worldwide suffer from dry eye disease. This condition causes discomfort, blurred vision, and a significant decline in quality of life. Traditional treatments, like eye drops and medications, often offer only temporary relief and may not effectively address underlying gland dysfunction.<\/p>\n<p>KouShiCare&#8217;s latest innovation, the LuminEyes Light Therapy Device, utilizes LLLT (Low-Level Light Therapy) and DWV\u2122 LLLT (Dual-Wavelength Low-Level Light Therapy) technology to promote cellular metabolism and tissue repair. The LLLT uses low-power LEDs, no more than 100mW\/cm\u00b2, to deliver precise red or near-infrared light to biological tissues while preventing thermal damage. Additionally, by irradiating the eyelids and Meibomian glands with LEDs at 600nm (visible red light) \uff5e\u00a0900nm (near-infrared light), DWV\u2122 LLLT stimulates ocular metabolism through PBM (photobiomodulation), harnessing biological regulatory effects to enhance eye health.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2738818\/LuminEyes_Light_Therapy_Device.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2738818\/LuminEyes_Light_Therapy_Device.jpg?p=medium600\" title=\"LuminEyes Light Therapy Device\" alt=\"LuminEyes Light Therapy Device\" \/><\/a><br \/><span>LuminEyes Light Therapy Device<\/span><\/p>\n<\/div>\n<p>Numerous research and clinical studies have demonstrated that <b>Red Light Therapy<\/b>\u00a0effectively softens blocked Meibomian gland lipids, improves the tear film&#8217;s lipid layer, alleviates dryness and the sensation of a foreign body, and enhances tear film stability. Compared to traditional treatments, it delivers more significant results while offering greater convenience and comfort.<\/p>\n<p>KouShiCare&#8217;s commitment to innovation extends to user experience. The <i>LuminEyes<\/i> device is designed for ease of use, allowing patients to perform treatments comfortably at home. Key features include:<\/p>\n<ul type=\"disc\">\n<li>360-degree full coverage illumination ensuring uniform treatment<\/li>\n<li>Safe, non-invasive operation with no discomfort or downtime<\/li>\n<li>Integrated voice prompts and soothing background music to enhance the user experience<\/li>\n<li>Auto shut-off function and thermal management for added safety and energy efficiency<\/li>\n<\/ul>\n<p>The <i>LuminEyes Light Therapy Device<\/i> is now available exclusively through the KouShiCare online store, offering a limited-time introductory discount of <b>15%<\/b>. Patients seeking an effective, safe, and user-friendly solution to dry eye symptoms are encouraged to explore the benefits of this innovative device.<\/p>\n<p>Visit us online for more details and purchase: <u><a href=\"https:\/\/koushicare.com\/products\/koushicare-lumineyes-light-therapy-mask\" target=\"_blank\" rel=\"nofollow\">https:\/\/koushicare.com\/products\/koushicare-lumineyes-light-therapy-mask<\/a><\/u><\/p>\n<div class=\"PRN_ImbeddedAssetReference\">  <\/div>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">HONG KONG<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 27, 2025<\/span><\/span> \/PRNewswire\/ &#8212; KouShiCare, a leading innovator in healthcare technology, is proud to announce a groundbreaking advancement in the treatment of dry eye disease. The company&#8217;s latest device harnesses the power of DWV\u2122 Low-Level Laser Therapy (LLLT) technology, marking a significant step forward in light-based ocular care.<\/p>\n<p>Approximately 344 million people worldwide suffer from dry eye disease. This condition causes discomfort, blurred vision, and a significant decline in quality of life. Traditional treatments, like eye drops and medications, often offer only temporary relief and may not effectively address underlying gland dysfunction.<\/p>\n<p>KouShiCare&#8217;s latest innovation, the LuminEyes Light Therapy Device, utilizes LLLT (Low-Level Light Therapy) and DWV\u2122 LLLT (Dual-Wavelength Low-Level Light Therapy) technology to promote cellular metabolism and tissue repair. The LLLT uses low-power LEDs, no more than 100mW\/cm\u00b2, to deliver precise red or near-infrared light to biological tissues while preventing thermal damage. Additionally, by irradiating the eyelids and Meibomian glands with LEDs at 600nm (visible red light) \uff5e\u00a0900nm (near-infrared light), DWV\u2122 LLLT stimulates ocular metabolism through PBM (photobiomodulation), harnessing biological regulatory effects to enhance eye health.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2738818\/LuminEyes_Light_Therapy_Device.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2738818\/LuminEyes_Light_Therapy_Device.jpg?p=medium600\" title=\"LuminEyes Light Therapy Device\" alt=\"LuminEyes Light Therapy Device\" \/><\/a><br \/><span>LuminEyes Light Therapy Device<\/span><\/p>\n<\/div>\n<p>Numerous research and clinical studies have demonstrated that <b>Red Light Therapy<\/b>\u00a0effectively softens blocked Meibomian gland lipids, improves the tear film&#8217;s lipid layer, alleviates dryness and the sensation of a foreign body, and enhances tear film stability. Compared to traditional treatments, it delivers more significant results while offering greater convenience and comfort.<\/p>\n<p>KouShiCare&#8217;s commitment to innovation extends to user experience. The <i>LuminEyes<\/i> device is designed for ease of use, allowing patients to perform treatments comfortably at home. Key features include:<\/p>\n<ul type=\"disc\">\n<li>360-degree full coverage illumination ensuring uniform treatment<\/li>\n<li>Safe, non-invasive operation with no discomfort or downtime<\/li>\n<li>Integrated voice prompts and soothing background music to enhance the user experience<\/li>\n<li>Auto shut-off function and thermal management for added safety and energy efficiency<\/li>\n<\/ul>\n<p>The <i>LuminEyes Light Therapy Device<\/i> is now available exclusively through the KouShiCare online store, offering a limited-time introductory discount of <b>15%<\/b>. Patients seeking an effective, safe, and user-friendly solution to dry eye symptoms are encouraged to explore the benefits of this innovative device.<\/p>\n<p>Visit us online for more details and purchase: <u><a href=\"https:\/\/koushicare.com\/products\/koushicare-lumineyes-light-therapy-mask\" target=\"_blank\" rel=\"nofollow\">https:\/\/koushicare.com\/products\/koushicare-lumineyes-light-therapy-mask<\/a><\/u><\/p>\n<div class=\"PRN_ImbeddedAssetReference\">  <\/div>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-28803","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/28803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28803"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/28803\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}